FDA
-
-
-
-
-
-
-
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
-
-
-
-
-
-
-
MediPharm (LABS) responds to Apollo allegations
-
-
-
-
-
-
-
MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health
-
-
-
-
-
-
-
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
-
-
-
-
-
-
-
MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program
-
-
-
-
-
-
-
MediPharm Labs Provides Update on Clinical Trial Progress Including FDA Approval of Partner Study
-
-
-
-
-
-
-
MediPharm Reports Second Quarter 2021 Results and Advances Pharmaceutical Strategy; Announces new Board Chair
-
325,624 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

